Porphyromonas gingivalis vaccine - SIGA

Drug Profile

Porphyromonas gingivalis vaccine - SIGA

Alternative Names: Periodontal disease vaccine - SIGA

Latest Information Update: 22 Sep 2014

Price : $50

At a glance

  • Originator Nonindustrial source; SIGA Technologies
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Periodontal disorders

Most Recent Events

  • 27 Apr 2005 Discontinued - Preclinical for Periodontal disorders in USA (unspecified route)
  • 20 Oct 1999 New profile
  • 20 Oct 1999 Preclinical development for Periodontal disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top